首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   4864篇
  免费   248篇
  国内免费   184篇
耳鼻咽喉   36篇
儿科学   29篇
妇产科学   57篇
基础医学   263篇
口腔科学   37篇
临床医学   487篇
内科学   577篇
皮肤病学   66篇
神经病学   95篇
特种医学   478篇
外科学   447篇
综合类   548篇
预防医学   443篇
眼科学   23篇
药学   1399篇
中国医学   92篇
肿瘤学   219篇
  2023年   20篇
  2022年   9篇
  2021年   7篇
  2020年   19篇
  2018年   32篇
  2017年   33篇
  2016年   45篇
  2015年   50篇
  2014年   50篇
  2013年   80篇
  2012年   35篇
  2011年   255篇
  2010年   135篇
  2009年   133篇
  2008年   119篇
  2007年   87篇
  2006年   94篇
  2005年   143篇
  2004年   459篇
  2003年   428篇
  2002年   351篇
  2001年   308篇
  2000年   196篇
  1999年   265篇
  1998年   311篇
  1997年   311篇
  1996年   222篇
  1995年   171篇
  1994年   164篇
  1993年   222篇
  1992年   115篇
  1991年   70篇
  1990年   50篇
  1989年   41篇
  1988年   25篇
  1987年   27篇
  1986年   28篇
  1985年   26篇
  1984年   17篇
  1983年   17篇
  1982年   21篇
  1981年   22篇
  1980年   9篇
  1979年   6篇
  1978年   11篇
  1977年   11篇
  1975年   6篇
  1974年   6篇
  1970年   3篇
  1967年   4篇
排序方式: 共有5296条查询结果,搜索用时 0 毫秒
31.
某地13所医院1997-2001年门诊费用的基本分析与评价   总被引:7,自引:0,他引:7  
采用回顾性调查分析方法,对某地13所医院1997-2001年门诊费用变动情况进行分析。统计学处理结果提示样本医院5年来门诊费用平均发展速度和平均增长速度加快明显。作者对此提出借鉴国外教训、避免浪费的建议,以应对医疗费飞涨给全局工作带来的各种冲击。  相似文献   
32.
Risperidone was effective in successfully treating a patient's negative symptoms of schizophrenia as well as reducing adverse effects from typical antipsychotic drugs. Auditory hallucinations reemerged after 8 months, however, and again after 24 months of risperidone therapy. Reemergence of psychotic symptoms after initial response might be explained by inadequate dosage, by the natural course of the patient's schizophrenia independent of drug therapy, or by the possibility that, for this patient, risperidone was less effective than chlorpromazine for the positive symptom of auditory hallucinations.  相似文献   
33.
34.
Study Objective . To determine if one commercial extended-release formulation of nifedipine (Adalat CC) is as effective as another (Procardia XL) in controlling blood pressure over 24 hours. Design . Open-label, randomized, crossover study. Setting . University-affiliated family medicine clinic. Patients . Fifteen patients with stage 1–4 primary hypertension. Interventions . Procardia XL or Adalat CC once/day was titrated to achieve blood pressure control. The effective dose was continued for 4 weeks, washed out for 1 week, and reinstituted with other study drug. Measurements and Main Results . Twenty-four-hour ambulatory blood pressure was recorded the conclusion of each treatment phase. Treatment phases were compared for mean 24-hour blood pressure, mean daytime (6:00 a.m.–10:00 p.m.) and mean nighttime blood pressure, and mean blood pressure load (percentage of blood pressure measurements < 140/90 mm Hg daytime and > 120/80 mm Hg nighttime). Thirteen patients completed the study. No statistically significant difference was seen in mean 24-hour blood pressure (138/86 mm Hg for Procardia XL vs 137/85 mm Hg for Adalat CC), daytime or nighttime blood pressure, or blood pressure load. Two patients experienced clinically significant adverse effects while taking Adalat CC. Conclusions . In these patients with primary hypertension, Adalat CC was as effective as Procardia XL at controlling blood pressure for 24 hours. Blood pressure, heart rate, and adverse effects should be monitored 2–4 weeks after any exchange of Adalat CC for Procardia XL.  相似文献   
35.
We performed a literature search for all clinical studies reporting outcomes in patients with the acquired immunodeficiency syndrome (AIDS) receiving granulocyte-macrophage colony-stimulating factor (GM-CSF) for any indication. Safety outcomes included human immunodeficiency virus replication, immune status, and frequency of opportunistic infections and neoplasms. Data were synthesized qualitatively. We identified 22 studies (274 patients): 12 addressed AIDS neutropenia, 8 AIDS cancer therapy, and 2 opportunistic infections. Viral burden was assessed by serum p24Ag in 15 studies. Nine reported no change in levels, three net decreases, and three net increases. All studies showing net increases involved patients receiving GM-CSF without a concurrent antiretroviral. The CD4 counts were unchanged in 5 studies, increased in 3, and not reported in 14. The incidence of neoplasms or new opportunistic infections was low. The literature suggests no increased risk of viral replication or clinical deterioration in patients with AIDS who take GM-CSF concurrently with zidovudine.  相似文献   
36.
Enterococci are the second most common cause of hospital-acquired infections, and drug resistance among these organisms is a growing problem. Vancomycin-resistant enterococci (VRE) now account for 7.9% of the nosocomial enterococcal infections. There is no standard therapy for VRE. Although some agents have shown in vitro activity alone or in combination, including ciprofloxacin, doxycycline, novobiocin, teicoplanin, chloramphenicol, and rifampin, treatment options are limited to combinations of drugs with marginal efficacy against the pathogens. Quinupristin-dalfopristin is a new investigational agent with activity against gram-positive cocci, including VRE.  相似文献   
37.
A 25–year-old woman was admitted to the hospital because of rising trough cyclosporine concentrations thought to be due to self-administration of 4 times the normal dosage of the drug for 8 days. Her symptoms included colicky central abdominal pains and urinary retention; her serum creatinine concentrations were elevated. Whole blood cyclosporine and metabolite concentrations were measured by high-performance liquid chromatography and monoclonal radioimmunoassays. The highest reported trough cyclosporine concentration was 5877 ng/ml, and AM1 (M17) concentration was 3425 ng/ml. A cyclosporine half-life of 91 hours was calculated. Nine days after the agent was discontinued the patient's serum creatinine concentration had returned to normal and her symptoms resolved. Due to the availability of three sizes of cyclosporine capsules, and the need for frequent dosage changes, continued vigilance is necessary to ensure that patients understand their drug regimen.  相似文献   
38.
39.
生物技术的迅速发展将导致一场新的药物革命。预计2000年世界生物技术药品的销售额将达500亿美元。美国、日本和西方工业化国家的制药公司对生物技术药品的开发非常重视。目前,人生长激素、红细胞生长素和人胰岛素在医药市场中占有重要位置,毫无疑问,二十一世纪的医药市场将是生物技术药品的时代。  相似文献   
40.
纤维支气管镜对右中叶肺不张的诊治价值(附50例报告)   总被引:1,自引:0,他引:1  
目的:探讨应用纤维支气管镜检查术在右中叶肺不张诊断和治疗中的价值。方法:对50例右中叶肺不张患者应用纤维支气管镜进行诊断和治疗。结果:50例右中叶肺不张中非特异性炎症29例、肺癌12例、结核3例、异物1例、未确定诊断5例,总确诊率90%(45/50);50例中33例经纤维支气管镜直视下局部治疗后复张,有效率66%(33/50),术后未见严重并发症。结论:纤维支气管镜对右中叶肺不张有一定的临床诊断和治疗价值。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号